Company profile RCKT
There is not enough data for Rocket Pharmaceuticals rocket pharmaceuticals to provide analysis
There is not enough data for Rocket Pharmaceuticals rocket pharmaceuticals to provide correlation calculation
There is not enough data for Rocket Pharmaceuticals rocket pharmaceuticals to provide analysis
After 39 days of this quarter the interest is at 282.0. Based on that we can calculate that during remaining 52 days it will total up to 658.0. rocket pharma expected interest is significantly higher compared to previous quarter (+86.9%) and same quarter last year (+83.3%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 51 | 190 272.5% QoQ | 335 76.3% QoQ | 107 -68.1% QoQ |
| 2020 | 294 476.5% YoY 174.8% QoQ | 249 31.1% YoY -15.3% QoQ | 164 -51.0% YoY -34.1% QoQ | 217 102.8% YoY 32.3% QoQ |
| 2021 | 362 23.1% YoY 66.8% QoQ | 128 -48.6% YoY -64.6% QoQ | 182 11.0% YoY 42.2% QoQ | 271 24.9% YoY 48.9% QoQ |
| 2022 | 301 -16.9% YoY 11.1% QoQ | 255 99.2% YoY -15.3% QoQ | 375 106.0% YoY 47.1% QoQ | 362 33.6% YoY -3.5% QoQ |
| 2023 | 359 19.3% YoY -0.8% QoQ | 435 70.6% YoY 21.2% QoQ | 549 46.4% YoY 26.2% QoQ | 352 -2.8% YoY -35.9% QoQ |
| 2024 | 282 -21.4% YoY -19.9% QoQ | - | - | - |
The average 5 years interest of rocket pharma was 22.3 per week. The last year interest of rocket pharma compared to the last 5 years has changed by 57.49%. The interest for rocket pharma is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 122.14%.
After 39 days of this quarter the interest is at 85.0. Based on that we can calculate that during remaining 52 days it will total up to 198.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 22 | 134 509.1% QoQ | 146 9.0% QoQ | 98 -32.9% QoQ |
| 2020 | 103 368.2% YoY 5.1% QoQ | 61 -54.5% YoY -40.8% QoQ | 198 35.6% YoY 224.6% QoQ | 297 203.1% YoY 50.0% QoQ |
| 2021 | 172 67.0% YoY -42.1% QoQ | 241 295.1% YoY 40.1% QoQ | 114 -42.4% YoY -52.7% QoQ | 125 -57.9% YoY 9.6% QoQ |
| 2022 | 89 -48.3% YoY -28.8% QoQ | 142 -41.1% YoY 59.6% QoQ | 180 57.9% YoY 26.8% QoQ | 89 -28.8% YoY -50.6% QoQ |
| 2023 | 288 223.6% YoY 223.6% QoQ | 143 0.7% YoY -50.3% QoQ | 252 40.0% YoY 76.2% QoQ | 243 173.0% YoY -3.6% QoQ |
| 2024 | 85 -70.5% YoY -65.0% QoQ | - | - | - |
The average 5 years interest of rocket pharmaceuticals stock was 12.34 per week. The last year interest of rocket pharmaceuticals stock compared to the last 5 years has changed by 34.93%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 94.06%.
After 39 days of this quarter the interest is at 53.0. Based on that we can calculate that during remaining 52 days it will total up to 124.0. rocket pharmaceuticals news expected interest is significantly higher compared to same quarter last year (+87.9%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 79 | 177 124.1% QoQ | 172 -2.8% QoQ | 36 -79.1% QoQ |
| 2020 | 159 101.3% YoY 341.7% QoQ | 58 -67.2% YoY -63.5% QoQ | 125 -27.3% YoY 115.5% QoQ | 84 133.3% YoY -32.8% QoQ |
| 2021 | 176 10.7% YoY 109.5% QoQ | 241 315.5% YoY 36.9% QoQ | 105 -16.0% YoY -56.4% QoQ | 112 33.3% YoY 6.7% QoQ |
| 2022 | 87 -50.6% YoY -22.3% QoQ | 24 -90.0% YoY -72.4% QoQ | 114 8.6% YoY 375.0% QoQ | 73 -34.8% YoY -36.0% QoQ |
| 2023 | 66 -24.1% YoY -9.6% QoQ | 142 491.7% YoY 115.2% QoQ | 141 23.7% YoY -0.7% QoQ | 129 76.7% YoY -8.5% QoQ |
| 2024 | 53 -19.7% YoY -58.9% QoQ | - | - | - |
The average 5 years interest of rocket pharmaceuticals news was 9.02 per week. The last year interest of rocket pharmaceuticals news compared to the last 5 years has changed by 8.98%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 10.2%.
There is not enough data for rare disease gene therapy to provide analysis
There is not enough data for rare disease gene therapy to provide correlation calculation
There is not enough data for rare disease gene therapy to provide analysis
There is not enough data for fanconi anemia gene therapy to provide analysis
There is not enough data for fanconi anemia gene therapy to provide correlation calculation
There is not enough data for fanconi anemia gene therapy to provide analysis
Google Trends for leukocyte adhesion deficiency treatment
Not enough data for reliable calculations!
There is not enough data for leukocyte adhesion deficiency treatment to provide analysis
There is not enough data for leukocyte adhesion deficiency treatment to provide correlation calculation
There is not enough data for leukocyte adhesion deficiency treatment to provide analysis
There is not enough data for pyruvate kinase deficiency cure to provide analysis
There is not enough data for pyruvate kinase deficiency cure to provide correlation calculation
There is not enough data for pyruvate kinase deficiency cure to provide analysis
There is not enough data for danon disease gene therapy to provide analysis
There is not enough data for danon disease gene therapy to provide correlation calculation
There is not enough data for danon disease gene therapy to provide analysis
There is not enough data for gene therapy for lysosomal disorder to provide analysis
There is not enough data for gene therapy for lysosomal disorder to provide correlation calculation
There is not enough data for gene therapy for lysosomal disorder to provide analysis